The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to ointment base (vehicle) in subjects with Atopic Dermatitis (AD).
- Signed written informed consent - Diagnosis of atopic dermatitis according to Hanifin and Rajka Criteria - Willingness of subject to follow all study procedures - Willingness to avoid excessive exposure of diseased areas to natural or artificial sunlight
- Pregnancy and breast-feeding - Clinically relevant disease, which could interfere with the study conduct or the evaluation and interpretation of the study results - Clinically manifested immunosuppressive disorder or known history of malignant disease - History of relevant drug and/or food allergies
Berlin, Germany, 10589
E-mail: [email protected]
Phone: Not Available
Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of Mapracorat Ointment in Three Concentrations Over Max. 4 Weeks in Subjects With Atopic Dermatitis (AD)